Literature DB >> 19789346

Role of SV40 integration site at chromosomal interval 1q21.1 in immortalized CRL2504 cells.

Jinglan Liu1, Gurpreet Kaur, Vikramjit K Zhawar, Drazen B Zimonjic, Nicholas C Popescu, Raj P Kandpal, Raghbir S Athwal.   

Abstract

We have applied a functional gene transfer strategy to show the importance of viral integration site in cellular immortalization. The large tumor antigen of SV40 is capable of extending the cellular life span by sequestering tumor suppressor proteins pRB and p53 in virus-transformed human cells. Although SV40 large T antigen is essential, it is not sufficient for cellular immortalization, suggesting that additional alterations in cellular genes are required to attain infinite proliferation. We show here that the disruption of human chromosomal interval at 1q21.1 by SV40 integration can be an essential step for cellular immortalization. The transfer of a 150-kb bacterial artificial chromosome (BAC) clone, RP364B14, corresponding to viral integration site in CRL2504 cells, reverted their immortal phenotype. Interestingly, the BAC transfer clones of CRL2504 cells displayed characteristics of either senescence as shown by beta-galactosidase activity or apoptosis as revealed by positive staining with M30 CytoDEATH antibody. The SV40 integration at 1q21.1, in the vicinity of epidermal differentiation complex (EDC) genes, resulted in the down-regulation of the filaggrin (FLG) gene that is part of the EDC. FLG gene expression was increased in BAC transfer senescent and apoptotic clones. Our results suggest that the disruption of native genomic sequence by SV40 may alter expression of genes involved in senescence and apoptosis by modulating chromatin structure. These studies imply that identification of genes located in the vicinity of viral integration sites in human cancers may be helpful in developing new diagnostic and therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19789346      PMCID: PMC2913896          DOI: 10.1158/0008-5472.CAN-09-1003

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  44 in total

Review 1.  SV40-mediated immortalization.

Authors:  H L Ozer
Journal:  Prog Mol Subcell Biol       Date:  2000

2.  Fragile sites are preferential targets for integrations of MLV vectors in gene therapy.

Authors:  A C Bester; M Schwartz; M Schmidt; A Garrigue; S Hacein-Bey-Abina; M Cavazzana-Calvo; N Ben-Porat; C Von Kalle; A Fischer; B Kerem
Journal:  Gene Ther       Date:  2006-03-02       Impact factor: 5.250

3.  Maintenance of episomal SV40 genomes in GM637 human fibroblasts.

Authors:  K C Huang; E F Yamasaki; R M Snapka
Journal:  Virology       Date:  1999-09-30       Impact factor: 3.616

4.  Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression.

Authors:  B Kwabi-Addo; D Giri; K Schmidt; K Podsypanina; R Parsons; N Greenberg; M Ittmann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

5.  Isolation and characterization of human repetin, a member of the fused gene family of the epidermal differentiation complex.

Authors:  Marcel Huber; Georges Siegenthaler; Nicolae Mirancea; Ingo Marenholz; Dean Nizetic; Dirk Breitkreutz; Dietmar Mischke; Daniel Hohl
Journal:  J Invest Dermatol       Date:  2005-05       Impact factor: 8.551

6.  Selection for c-myc integration sites in polyclonal T-cell lymphomas.

Authors:  Dana R Broussard; Jennifer A Mertz; M Lozano; Jaquelin P Dudley
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

Review 7.  A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.

Authors:  Eileen F Dunne; S Deblina Datta; Lauri E Markowitz
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

8.  SV40-like DNA sequences in pleural mesothelioma, bronchopulmonary carcinoma, and non-malignant pulmonary diseases.

Authors:  F Galateau-Salle; P Bidet; Y Iwatsubo; E Gennetay; A Renier; M Letourneux; J C Pairon; S Moritz; P Brochard; M C Jaurand; F Freymuth
Journal:  J Pathol       Date:  1998-03       Impact factor: 7.996

9.  A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas.

Authors:  J R Testa; M Carbone; A Hirvonen; K Khalili; B Krynska; K Linnainmaa; F D Pooley; P Rizzo; V Rusch; G H Xiao
Journal:  Cancer Res       Date:  1998-10-15       Impact factor: 12.701

10.  Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas.

Authors:  Kamel Izeradjene; Chelsea Combs; Melissa Best; Aarthi Gopinathan; Amary Wagner; William M Grady; Chu-Xia Deng; Ralph H Hruban; N Volkan Adsay; David A Tuveson; Sunil R Hingorani
Journal:  Cancer Cell       Date:  2007-03       Impact factor: 31.743

View more
  3 in total

Review 1.  Simian virus 40 transformation, malignant mesothelioma and brain tumors.

Authors:  Fang Qi; Michele Carbone; Haining Yang; Giovanni Gaudino
Journal:  Expert Rev Respir Med       Date:  2011-10       Impact factor: 3.772

Review 2.  Association Between Simian Virus 40 and Human Tumors.

Authors:  John Charles Rotondo; Elisa Mazzoni; Ilaria Bononi; Mauro Tognon; Fernanda Martini
Journal:  Front Oncol       Date:  2019-07-25       Impact factor: 6.244

Review 3.  Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review).

Authors:  Drazen B Zimonjic; Nicholas C Popescu
Journal:  Int J Oncol       Date:  2012-05-10       Impact factor: 5.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.